Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia

Research output: Contribution to journalArticle

53 Citations (Scopus)
Original languageEnglish
JournalLeukemia Research
Volume36
Issue number1
DOIs
Publication statusPublished - Jan 2012

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

@article{241d33281ece42f9b752496ae9ec24f6,
title = "Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia",
author = "Orlandi, {Ester M.} and Barbara Rocca and Pazzano, {Anna S.} and Stefano Ghio",
year = "2012",
month = "1",
doi = "10.1016/j.leukres.2011.08.007",
language = "English",
volume = "36",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Ltd",
number = "1",

}

TY - JOUR

T1 - Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia

AU - Orlandi, Ester M.

AU - Rocca, Barbara

AU - Pazzano, Anna S.

AU - Ghio, Stefano

PY - 2012/1

Y1 - 2012/1

UR - http://www.scopus.com/inward/record.url?scp=83555176225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83555176225&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2011.08.007

DO - 10.1016/j.leukres.2011.08.007

M3 - Article

C2 - 21890201

AN - SCOPUS:83555176225

VL - 36

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 1

ER -